As the better class of newspapers are rejecting “patent medicine” advertising on their own volition, so are the better class of medical journals rejecting advertisements of fraudulent proprietaries. Some newspapers will continue to carry nostrum advertising until their subscribers raise a protest that will cause the business department to take notice; so, too, some medical journals will continue to share the profits with the nostrum exploiters until an outraged medical profession repudiates such publications.]--(_From The Journal A. M. A., Feb. 6, 1915._) [89] The Journal A. M. A., April 20, 1907, reprinted in “Propaganda for Reform,” 8th Edition. THIALION Report of the Council on Pharmacy and Chemistry The following report was submitted to the Council by a subcommittee which examined Thialion (Vass Chemical Company): _To the Council on Pharmacy and Chemistry_:--We beg leave to report on Thialion as follows: Thialion is sold by the Vass Chemical Co., Danbury, Conn. In the literature supplied to physicians and in the advertisements in medical journals, Thialion is stated to be “a laxative salt of lithia” with the chemical formula “3Li_{2}O.NaO.SO_{3}.7HO.” “Sodio-trilithic anhydrosulphate” is given as a synonym. An elaborate graphic or structural formula is also given. According to analyses, this preparation is a mixture consisting chiefly of sodium sulphate and sodium citrate with very small amounts of lithium, the average of several estimations indicating the following composition: Sodium citrate 58.6 Sodium sulphate, anhydrous 26.6 Sodium chlorid 3.3 Lithium citrate, anhydrous 1.8 Water 9.7 Thus, the advertising literature is a deliberate misrepresentation of the facts. It is, therefore, recommended that the preparation be refused recognition, and that this report be published. The recommendations of the subcommittee were adopted by the Council and in accordance therewith the above report is published. W. A. Puckner, Secretary.